Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis

International Immunology

Volumn 26, Issue 6, 2014, Pages 325-340

  Abd Allah, Adel R A ^a,b   Ahmad, Sheikh Fayaz ^a   Alrashidi, Ibrahim ^a   Abdel Hamied, Hala E ^c   Zoheir, Khairy M A ^a,d   Ashour, Abdelkader E ^a   Bakheet, Saleh A ^a   Attia, Sabry M ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

^c AL AZHAR UNIVERSITY   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

4 methylhistamine dihydrochloride; Chemokines; Collagen antibody induced arthritis; Cytokines; Histamine 4 receptor; Interleukin; JNJ77777120; mRNA expression; NF KB p65; Regulatory T cells; T cell subsets

Indexed keywords

4 METHYLHISTAMINE; ANTIRHEUMATIC AGENT; COLLAGEN ANTIBODY; COLLAGEN TYPE 2; CYTOKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTAMINE AGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; JNJ 77777120; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMA PROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1-((5-CHLORO-1H-INDOL-2-YL)CARBONYL)-4-METHYLPIPERAZINE; 4-METHYLHISTAMINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE DERIVATIVE; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PAW EDEMA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT DURATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; TH1 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPHENOTYPING; INDOLES; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTE ACTIVATION; MATRIX METALLOPROTEINASE 3; METHYLHISTAMINES; MICE; MICE, INBRED BALB C; NF-KAPPA B; PIPERAZINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; TH1 CELLS;

EID: 84901489940     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt075     Document Type: Article

References (68)

1. Cope, A. P., Schulze-Koops, H. and Aringer, M. 2007. The central role of T cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 25(Suppl. 46):S4.
2. Nguyen, T., Shapiro, D. A., George, S. R. et al. 2001. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. 59:427.
3. Oda, T., Morikawa, N., Saito, Y., Masuho, Y. and Matsumoto, S. 2000. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275:36781.
4. Taglialatela, M., Castaldo, P., Pannaccione, A., Secondo, M., Cataldi, F. and Boscia, F. 2004. First-and second-generation H1 antihistamines: from their molecular basis of their interaction with HERG K+ channels to physiological and pathophysiological implication. Clin. Exp. All. Rev. 4:183.
5. Coruzzi, G., Adami, M., Guaita, E., de Esch, I. J. and Leurs, R. 2007. Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur. J. Pharmacol. 563:240.
6. Morse, K. L., Behan, J., Laz, T. M. et al. 2001. Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther. 296:1058.
7. Dijkstra, D., Leurs, R., Chazot, P. et al. 2007. Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J. Allergy Clin. Immunol. 120:300.
8. Ikawa, Y., Suzuki, M., Shiono, S. et al. 2005. Histamine H4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biol. Pharm. Bull. 28:2016.
9. Sweeney, S. E. and Firestein, G. S. 2004. Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 36:372.
10. Frewin, D. B., Cleland, L. G., Jonsson, J. R. and Robertson, P. W. 1986. Histamine levels in human synovial fluid. J. Rheumatol. 13:13.
11. Morgan, R. K., McAllister, B., Cross, L. et al. 2007. Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J. Immunol. 178:8081.
12. Cowden, M. J., Riley, J. P., Ma, J. Y., Thurmond, R. L. and Dunford, P. J. 2010. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir. Res. 24:11.
13. Buckland, K. F., Williams, T. J. and Conroy, D. M. 2003. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br. J. Pharmacol. 140:1117.
14. Thurmond, R. L., Desai, P. J., Dunford, P. J. et al. 2004. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 309:404.
15. Hammaker, D., Sweeney, S. and Firestein, G. S. 2003. Signal transduction networks in rheumatoid arthritis. Ann. Rheum. Dis. 62(Suppl. 2):ii86.
16. Tak, P. P. and Firestein, G. S. 2001. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107:7.
17. Marok, R., Winyard, P. G., Coumbe, A., Kus, M. L. and Gaffney, K. 1996. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 39:583.
18. Tak, P. P., Gerlag, D. M., Aupperle, K. R. et al. 2001. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum. 44:1897.
19. Baldwin, A. S. Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
20. Miagkov, A. V., Kovalenko, D. V., Brown, C. E. et al. 1998. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl Acad. Sci. U. S. A. 95:13859.
21. Bondeson, J., Foxwell, B., Brennan, F. and Feldmann, M. 1999. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc. Natl Acad. Sci. U. S. A. 96:5668.
22. Amin, A. R., Attur, M. and Abramson, S. B. 1999. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr. Opin. Rheumatol. 11:202.
23. Thalhamer, T., McGrath, M. A. and Harnett, M. M. 2008. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 47:409.
24. Hutamekalin, P., Saito, T., Yamaki, K., Mizutani, N., Brand, D. D. and Waritani, T. 2009. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies. J. Immunol. Methods 343:49.
25. Jagdish, N. S., Awatef, M., Zaini, M. A. 2004. Comparison between plethysmometer and micrometer methods to measure acute paw oedema for screening anti-inflammatory activity in mice. Inflammopharmacology 12:89.
26. Woolley, D. E. 2003. The mast cell in inflammatory arthritis. N. Engl. J. Med. 348:1709.
27. Yamaura, K., Yonekawa, T., Nakamura, T., Yano, S. and Ueno, K. 2003. The histamine H2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine. J. Pharmacol. Sci. 92:43.
28. Cogé, F., Guénin, S. P., Rique, H., Boutin, J. A. and Galizzi, J. P. 2001. Structure and expression of the human histamine H4-receptor gene. Biochem. Biophys. Res. Commun. 284:301.
29. Liu, C., Ma, X. Jiang, X. et al. 2001. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol. Pharmacol. 59:420.
30. Gantner, F., Sakai, K., Tusche, M. W., Cruikshank, W. W., Center, D. M. and Bacon, K. B. 2002. Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J. Pharmacol. Exp. Ther. 303:300.
31. Kohka, H., Nishibori, M., Iwagaki, H. et al. 2000. Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells. J. Immunol. 164:6640.
32. Marone, G., Granata, F., Spadaro, G., Genovese, A. and Triggiani, M. 2003. The histamine-cytokine network in allergic inflammation. J. Allergy Clin. Immunol. 112(4 Suppl):S83.
33. Katoh, N., Soga, F., Nara, T., Masuda, K. and Kishimoto, S. 2005. Histamine induces the generation of monocyte-derived dendritic cells that express CD14 but not CD1a. J. Invest. Dermatol. 125:753.
34. Elenkov, I. J., Webster, E., Papanicolaou, D. A., Fleisher, T. A., Chrousos, G. P. and Wilder, R. L. 1998. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161:2586.
35. Gutzmer, R., Mommert, S., Gschwandtner, M., Zwingmann, K., Stark, H. and Werfel, T. 2009. The histamine H4 receptor is functionally expressed on T(H)2 cells. J. Allergy Clin. Immunol. 123:619.
36. Ferenczi, K., Burack, L., Pope, M., Krueger, J. G. and Austin, L. M. 2000. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J. Autoimmun. 14:63.
37. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
38. Baecher-Allan, C., Viglietta, V. and Hafler, D. A. 2004. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 16:89.
39. Dombrecht, E. J., Aerts, N. E., Schuerwegh, A. J. et al. 2006. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 24:31.
40. Cao, D., van Vollenhoven, R., Klareskog, L., Trollmo, C. and Malmström, V. 2004. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6:R335.
41. Nocentini, G. and Riccardi, C. 2005. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 35:1016.
42. Shevach, E. M. and Stephens, G. L. 2006. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6:613.
43. Ji, H. B., Liao, G., Faubion, W. A. et al. 2004. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172:5823.
44. Stephens, G. L., McHugh, R. S., Whitters, M. J. et al. 2004. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J. Immunol. 173:5008.
45. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
46. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. 2008. Regulatory T cells and immune tolerance. Cell 133:775.
47. Ehrenstein, M. R., Evans, J. G., Singh, A. et al. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200:277.
48. McInnes, I. B. and Schett, G. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7:429.
49. Raza, K., Falciani, F., Curnow, S. J. et al. 2005. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7:R784.
50. Wilson, N. J., Boniface, K., Chan, J. R. et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950.
51. Sawai, T., Uzuki, M., Harris, E. D. Jr, Kurkinnen, M., Trelstad, R. L. and Hayashi, M. 1996. In situ hybridization of stromelysin mRNA in the synovial biopsies from rheumatoid arthritis. Tohoku J. Exp. Med. 178:315.
52. Choy, E. H. and Panayi, G. S. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344:907.
53. Kagari, T., Doi, H. and Shimozato, T. 2002. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 169:1459.
54. Borzì, R. M., Mazzetti, I., Cattini, L., Uguccioni, M., Baggiolini, M. and Facchini, A. 2000. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum. 43:1734.
55. Sakurada, S., Kato, T. and Okamoto, T. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-Lcysteine and aspirin. Int. Immunol. 8:1483.
56. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B. et al. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50:650.
57. Lubberts, E., Joosten, L. A., Oppers, B. et al. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167:1004.
58. Massagué, J., Blain, S. W. and Lo, R. S. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295.
59. Strober, W., Kelsall, B., Fuss, I. et al. 1997. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol. Today 18:61.
60. Simmonds, R. E. and Foxwell, B. M. 2008. Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 47:584.
61. Brown, K. D., Claudio, E. and Siebenlist, U. 2008. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res. Ther. 10:212.
62. Amin, A. R., Attur, M. and Abramson, S. B. 1999. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr. Opin. Rheumatol. 11:202.
63. Bingham, C. O. 3rd. 2002. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol. Suppl. 65:3
64. Li, P., Sanz, I., O'Keefe, R. J. and Schwarz, E. M. 2000. NF-kappa B regulates VCAM-1 expression on fibroblast-like synoviocytes. J. Immunol. 164:5990.
65. Makarov, S. S., Johnston, W. N., Olsen, J. C. et al. 1997. NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Ther. 4:846.
66. Bondeson, J., Foxwell, B., Brennan, F. and Feldmann, M. 1999. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc. Natl Acad. Sci. U. S. A. 96:5668.
67. Gilmore, T. D. and Garbati, M. R. 2011. Inhibition of NF-?B signaling as a strategy in disease therapy. Curr. Top. Microbiol. Immunol. 349:245.
68. Zheng, W. and Flavell, R. A. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.